title: [Construction of recombinant adeno-associated virus vector with human bone morphogenetic protein].
abstract: OBJECTIVE
  To construct the recombinant adeno-associated virus vector with human bone morphogenetic protein 4 gene (AAV-hBMP-4).
  
  
  METHODS
  The hBMP-4 gene primer was designed basing on the corresponding gene sequence in GenBank. EcoR I site was introduced into the upstream of the primer and Sal I site into downstream. The hBMP-4 gene was amplified with the template of EX-A0242-M01-hBMP-4, then was cloned into pUC18 vector to construct recombinant plasmid pUC18-hBMP-4. The plasmids pUC18-hBMP-4 and plasmid pSNAV cut by EcoR I and Sal I enzyme, the fragments were collected and linked with T4 DNA ligase at 16 C over night, recombinant plasmid pSNAV-hBMP-4 was obtained. The recombinant plasmid was then transfected into BHK21 cells using Lipofectamine TM2000. The G418 resistant cells were obtained consequently. These cells were infected with HSV1-rc/deltaUL2 which has the function of packaging and copying the recombinant AAV. After purification, the construction of recombinant AAV-hBMP-4 was completed.
  
  
  RESULTS
  The construction of the recombinant pSNAV-hBMP-4 was confirmed by PCR electrophoresis and digestion with restriction enzyme. The gene sequence in the recombinant pSNAV-hBMP-4 was correct. The virus titer was about 1.5 x 10(12) microg/ml. The purity of the virus was more than 95% using the SDS-PAGE method.
  
  
  CONCLUSIONS
  With this method, high virus titers and purity of AAV-hBMP-4 can be acquired successfully and it is useful to bone tissue engineering.
authors: Department of Orthopaedics, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou Guangdong, 510080, PR China. dongzhiyong12@yahoo.com.cn
authors: Zhiyong
authors: Z
authors: Dong
authors: Zhaomin
authors: Z
authors: Zheng
authors: Guanming
authors: G
authors: Kuang
mesh_terms: D055415:Bone Morphogenetic Protein 4 / Q000235:genetics*; D002460:Cell Line; D003001:Cloning, Molecular; D000229:Dependovirus / Q000235:genetics*; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D010957:Plasmids / Q000235:genetics; D016133:Polymerase Chain Reaction / Q000379:methods; D011995:Recombination, Genetic; D023822:Tissue Engineering
chemical_list: C525809:BMP4 protein, human; D055415:Bone Morphogenetic Protein 4